Quarterly report pursuant to Section 13 or 15(d)

Derivative Liability -Warrants (Details Narrative)

v3.20.1
Derivative Liability -Warrants (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Jan. 08, 2019
May 31, 2018
May 31, 2018
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Sep. 30, 2019
Warrant upper exercise price $ 0.75            
Warrant lower exercise price $ 0.40            
Additional warrant issued $ 2,023,438            
Fair value of the derivative liability       $ 141,000   $ 316,000  
Cumulative changes in fair value       $ 175,000   0  
Warrant description       In conjunction with the Series D Preferred financing (See Note 14), the Company offered the Series B warrant holders the option to exchange their warrants on the basis of 1 warrant for 0.40 common shares.      
Fair value of warrants       $ 73,000      
Change in fair value of redemption put liability       193,659    
Change in fair value of derivative liability - warrants       174,978    
Redemption put liability [1]       $ 79,045   $ 267,399  
Series B Warrants [Member]              
Warrants to purchase common stock       403,125      
Fair value of the derivative liability             $ 1,200,000
Warrants       1,007,813      
Fair value of warrants       $ 75,000      
Securities Purchase Agreement [Member]              
Number of shares issued     108,250        
Securities Purchase Agreement [Member] | Series B Warrants [Member]              
Warrants to purchase common stock   2,312,500 2,312,500        
Warrant term   3 years 3 years        
Warrant upper exercise price   $ 0.75          
[1] The Company did not have any assets or liabilities measured at fair value using Level 1 or 2 of the fair value hierarchy as of March 31, 2020 and December 31, 2019.